snoRA71 is highly expressed and has been identified as a prognostic marker of lung cancer (57, 58), hepatocellular carcinoma (HCC) (59), multiple myeloma (60), and colorectal cancer (61). Here, SNORA71 is linked to AL amyloidosis.